Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Reexamination Certificate
2008-06-03
2008-06-03
Ungar, Susan (Department: 1642)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
C530S324000, C530S326000
Reexamination Certificate
active
07381701
ABSTRACT:
The present invention relates to compositions and methods of use of cupredoxins, and variants, derivatives and structural equivalents of cupredoxins that interfere with the ephrin signaling system in mammalian cells. Specifically, the invention relates to compositions and methods that use cupredoxins, such as azurin, rusticyanin and plastocyanin, and variants, derivatives and structural equivalents thereof, to treat cancer in mammals.
REFERENCES:
patent: 5210019 (1993-05-01), Margalit
patent: 2003/0105000 (2003-06-01), Pero et al.
patent: WO 02/076380 (2002-10-01), None
Bowie et al (Science, 1990, 257:1306-1310).
Burgess et al (J of Cell Bio. 111:2129-2138, 1990).
Lazar et al (Molecular and Cellular Biology, 1988, 8:1247-1252).
Scott et al (Nature Genetics, 1999, 21:440-443).
Bork (Genome Research, 2000, 10:398-400).
Freshney (Culture of Animal Cells, A Manual of Basic Technique, Alan R. Liss, Inc., 1983, New York, p. 4).
Dermer (Bio/Technology, 1994, 12:320).
Drexler et al (Leukemia and Lymphoma, 1993, 9:1-25).
Zellner et al (Clin. Can. Res., 1998, 4:1797-17802).
Zips et al (In vivo, 2005, 19:1-8).
Gura (Science, 1997, 278:1041-1042).
Kaiser (Science, 2006, 313, 1370).
Canters (FEBS Letters, 1987, 212:168-172).
Voet and Voet (Biochemistry, 1990, p. 298-301).
Stratagene Catalog 1988, p. 39.
Yamada T, et al.,“Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity”,Cell Microbiol.Oct. 2005; 7(10):1418-31.
Yamada T, et al., “Rusticyanin, a bacterial electron transfer protein, causes G1 arrest in J774 and apoptosis in human cancer cells”,Cell CycleSep. 2004; 3(9):1182-7.
Yamada T, et al.,“Regulation of mammalian cell growth and death by bacterial redox proteins: relevance to ecology and cancer therapy”,Cell CycleJun. 2004;3(6):752-5.
Hiraoka Y , et al., “Modulation of mammalian cell growth and death by prokaryotic and eukaryotic cytochrome c”,Proc Natl Acad Sci U S A.Apr. 27, 2004;101(17):6427-32.
Yamada T, et al., “Apoptosis or growth arrest: Modulation of tumor suppressor p53's specificity by bacterial redox protein azurin”,Proc Natl Acad Sci U S A.Apr. 6, 2004; 101(14):4770-5.
Punj V, et al., “Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer”,OncogeneMar. 25, 2004;23(13):2367-78.
Chakrabarty AM, “Microorganisms and Cancer: Quest for a Therapy”,J. Bacteriol. 185(9):2683-86.
Punj V, et al., “Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53”,Biochem Biophys Res Commun. Dec. 5, 2003;312(1):109-14.
Punj V, et al., “Energy-generating enzymes ofBurkholderia cepaciaand their interactions with macrophages”,J Bacteriol. May 2003;185(10):3167-78.
Goto M, et al., “Induction of apoptosis in macrophages byPseudomonas aeruginosaazurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity”,Mol Microbiol. Jan. 2003;47(2):549-59.
Yamada T, et al., “The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53”,Infect Immun. Dec. 2002;70(12):7054-62.
Yamada T, et al., “Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer”,Proc Natl Acad Sci U S A. Oct. 29, 2002;99(22):14098-103. Epub Oct. 22, 2002.
Zaborina O, et al., “P2Z-Independent and P2Z receptor-mediated macrophage killing byPseudomonas aeruginosaisolated from cystic fibrosis patients”,Infect Immun. Oct. 1999;67(10):5231-42.
Zaborina O, et al., “Secreted products of a nonmucoidPseudomonas aeruginosastrain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis”,MicrobiologyOct. 2000; 146 ( Pt 10):2521-30.
Yang D., et al., “Bacterial redox protein azurin induce apoptosis in human osteosarcoma U2OS cells”,Pharmacological Research2005 52(5):413-421.
Apiyo D. and Wittung-Stafshede, P., “Unique complex between bacterial azurin and tumor-suppressor protein p53”,Bioche. Biophys. Res. Comm.2005 332: 965-968.
Ye, Z., et al. “Selective inducement effect of bacterial redox protein azurin on apoptosis of human osteosarcoma cell line U2OS”,Chinese Journal of Cancer2005, 24(3): 298-304.
Yamada et al., “The Bacterial Redox Protein Azurin Induces Apoptosis in J774 Macrophages through Complex Formation and Stabilization of the Tumor Suppressor Protein p53”,Infection and Immunity, vol. 70 (12), Dec. 2002, pp. 7054-7062.
Anonymous: “Plastocyanin precursor” Database EMBL, Online, Nov. 1, 1997, XP002306632 abstract.
Anonymous: “Rusticyanin precursor” Database EMBL, Online, Mar. 1, 1992, XP002306633 abstract.
Anonymous: “Pseudoazurin precursor” Database EMBL, Online, Feb. 1, 1991, XP002306634 abstract.
Yamada T, et al., “Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity”,Cell Microbiol.Oct. 2005; 7(10):1418-31.
Yamada T, et al., “Internalization of bacterial redox protein azurin in mammalian cells: entry domain and specificity”,Cell Microbiol. Oct. 2005;7(10):1418-31.
Yamada T, et al., “Rusticyanin, a bacterial electron transfer protein, causes G1 arrest in J774 and apoptosis in human cancer cells”,Cell CycleSep. 2004;3(9):1182-7.
Yamada T, et al., “Regulation of mammalian cell growth and death by bacterial redox proteins: relevance to ecology and cancer therapy”,Cell CycleJun. 2004;3(6):752-5.
Hiraoka Y, et al., “Modulation of mammalian cell growth and death by prokaryotic and eukaryotic cytochrome c”,Proc Natl Acad Sci U S A. Apr. 27, 2004;101(17):6427-32.
Yamada T, et al., “Apoptosis or growth arrest: Modulation of tumor suppressor p53's specificity by bacterial redox protein azurin”,Proc Natl Acad Sci U S A. Apr. 6, 2004;101(14):4770-5.
Punj V, et al., “Bacterial cupredoxin azurin as an inducer of apoptosis and regression in human breast cancer”,OncogeneMar. 25, 2004;23(13):2367-78.
Chakrabarty AM, “Microorganisms and Cancer: Quest for a Therapy”,J. Bacteriol. 185(9):2683-86, May, 2003.
Punj V, et al., “Bacterial cupredoxin azurin and its interactions with the tumor suppressor protein p53”,Biochem Biophys Res Commun. Dec. 5, 2003;312(1):109-14.
Punj V, et al., “Energy-generating enzymes ofBurkholderia cepaciaand their interactions with macrophages”,J Bacteriol. May 2003;185(10):3167-78.
Goto M, et al., “Induction of apoptosis in macrophages byPseudomonas aeruginosaazurin: tumour-suppressor protein p53 and reactive oxygen species, but not redox activity, as critical elements in cytotoxicity”,Mol Microbiol.Jan. 2003;47(2):549-59.
Yamada T, et al., “The bacterial redox protein azurin induces apoptosis in J774 macrophages through complex formation and stabilization of the tumor suppressor protein p53”,Infect Immun.Dec. 2002;70(12):7054-62.
Yamada T, et al., “Bacterial redox protein azurin, tumor suppressor protein p53, and regression of cancer”,Proc Natl Acad Sci U S A. Oct. 29, 2002;99(22):14098-103. Epub Oct. 22, 2002.
Zaborina O, et al., “P2Z-Independent and P2Z receptor-mediated macrophage killing byPseudomonas aeruginosaisolated from cystic fibrosis patients”,Infect Immun.Oct. 1999;67(10):5231-42.
Zaborina O, et al., “Secreted products of a nonmucoidPseudomonas aeruginosastrain induce two modes of macrophage killing: external-ATP-dependent, P2Z-receptor-mediated necrosis and ATP-independent, caspase-mediated apoptosis”,MicrobiologyOct. 2000; 146 ( Pt 10):2521-30.
Yang D., et al., “Bacterial redox protein azurin induce apoptosis in human osteosarcoma U2OS cells”,Pharmacological Research2005 52(5):413-421
Chakrabarty Ananda
Chaudhari Anita
Das Gupta Tapas
Fialho Arsenio
Yamada Tohru
Reddig Peter J.
Sheppard Mullin Richter & Hampton LLP
The Borad of Trustees of the University of Illinois
Ungar Susan
LandOfFree
Compositions and methods for treating conditions related to... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Compositions and methods for treating conditions related to..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Compositions and methods for treating conditions related to... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2803926